Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 9;11:697247. doi: 10.3389/fonc.2021.697247

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Li, Wang, Chen, Cao, Zhang, Gu, Qi, Fei, Shi, Li, Li, Wang and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Analysis of potential biomarkers associated with anlotinib plus XHW in the treatment of lung cancer in ESI+ mode. (A) Results of the OPLS-DA model using the data from the anlotinib/XHW group vs the anlotinib group. (B) S-score plot constructed from the supervised OPLS analysis of the anlotinib/XHW group vs the anlotinib group. (C) Results of the OPLS-DA model using the data from the anlotinib/XHW group vs the XHW group. (D) S-score plot constructed from the supervised OPLS analysis of the anlotinib/XHW group vs the XHW group. Metabolite ions with variable influence on the projection (VIP) values >1 and |p(corr)| ≥ 0.5 are marked with a red square. The x-axis represents the co-correlation coefficient between the principal component and the metabolite, and the y-axis represents the correlation coefficient between the principal component and the metabolite. (E) Venn diagram of metabolites showing the overlap between the anlotinib/XHW, anlotinib, and XHW groups.